All Stories

  1. Foreword

    Article • Current Pharmaceutical Design, January 2024, Bentham Science Publishers

    Dr Alessandro Antonelli

  2. Covid-19 And Rheumatic Autoimmune Systemic Diseases: Role of Pre-Existing Lung Involvement and Ongoing Treatments

    Article • Current Pharmaceutical Design, November 2021, Bentham Science Publishers

    Dr Francesca Ingegnoli, Corrado Campochiaro, Laura Gragnani, Dr Simone Barsotti, Dr Alessandro Antonelli, Rosario Foti, Raffaele Brittelli, Daniela Scorpiniti, Ylenia Dal Bosco, Rodolfo Caminiti

  3. The Covid-19, Epidemiology, Clinic and Prevention

    Article • Current Genomics, July 2020, Bentham Science Publishers

    Dr Alessandro Antonelli

  4. Immunomodulation of CXCL10 Secretion by Hepatitis C Virus: Could CXCL10 Be a Prognostic Marker of Chronic Hepatitis C?

    Article • Journal of Immunology Research, August 2019, Hindawi Publishing Corporation

    Dr Alessandro Antonelli, Armando Patrizio

  5. Evaluating vandetanib in the treatment of medullary thyroid cancer: patient-reported outcomes

    Article • Cancer Management and Research, August 2019, Taylor & Francis

    Dr Alessandro Antonelli, Armando Patrizio

  6. Sunitinib in the Treatment of Thyroid Cancer

    Article • Current Medicinal Chemistry, May 2019, Bentham Science Publishers

    Dr Alessandro Antonelli

  7. Genotoxicity Evaluation of the Soybean Isoflavone Genistein in Human Papillary Thyroid Cancer Cells. Study of Its Potential Use in Thyroid Cancer Therapy

    Article • Nutrition and Cancer, April 2019, Taylor & Francis

    Dr Alessandro Antonelli

  8. Recent advances in precision medicine for the treatment of anaplastic thyroid cancer

    Article • Expert Review of Precision Medicine and Drug Development, January 2019, Taylor & Francis

    Professor Concettina La Motta, Professor Salvatore Ulisse, Dr Alessandro Antonelli, Armando Patrizio

  9. Breg Cells in Celiac Disease Isolated or Associated to Hashimoto’s Thyroiditis

    Article • International Journal of Endocrinology, October 2018, Hindawi Publishing Corporation

    Dr Alessandro Antonelli

  10. CTLA-4 and PD-1 Ligand Gene Expression in Epithelial Thyroid Cancers

    Article • International Journal of Endocrinology, July 2018, Hindawi Publishing Corporation

    Dr Alessandro Antonelli, mian caterina, Professor Salvatore Ulisse, Prof. FRANCESCO TARTAGLIA

  11. CCL2 is Modulated by Cytokines and PPAR-γ in Anaplastic Thyroid Cancer

    Article • Anti-Cancer Agents in Medicinal Chemistry, June 2018, Bentham Science Publishers

    Professor Salvatore Ulisse, Dr Alessandro Antonelli

  12. Lenvatinib in the Therapy of Aggressive Thyroid Cancer: State of the A rt and New Perspectives with Patents Recently Applied

    Article • Recent Patents on Anti-Cancer Drug Discovery, May 2018, Bentham Science Publishers

    Dr Alessandro Antonelli

  13. Novel treatment options for anaplastic thyroid cancer

    Article • Expert Review of Endocrinology & Metabolism, June 2017, Taylor & Francis

    Professor Salvatore Ulisse, Dr Alessandro Antonelli

  14. Chemokines in the Pathogenesis and as Therapeutical Markers and Targets of HCV Chronic Infection and HCV Extrahepatic Manifestations

    Article • Current Drug Targets, April 2017, Bentham Science Publishers

    Dr Alessandro Antonelli

  15. Tyrosine Kinase Inhibitors; Therapies for Thyroid Cancer

    Article • January 2016, Bentham Science Publishers

    Professor Salvatore Ulisse, Dr Alessandro Antonelli

  16. Pyrazolopyrimidine Derivatives as Antineoplastic Agents: with a Special Focus on Thyroid Cancer

    Article • Mini-Reviews in Medicinal Chemistry, November 2015, Bentham Science Publishers

    Dr Alessandro Antonelli

  17. Cabozantinib in Thyroid Cancer

    Article • Recent Patents on Anti-Cancer Drug Discovery, September 2015, Bentham Science Publishers

    Dr Alessandro Antonelli

  18. Selective use of vandetanib in the treatment of thyroid cancer

    Article • Drug Design Development and Therapy, July 2015, Taylor & Francis

    Dr Alessandro Antonelli

  19. Targeting Chemokine (C-X-C motif) Receptor 3 in Thyroid Autoimmunity

    Article • Recent Patents on Endocrine Metabolic & Immune Drug Discovery, July 2014, Bentham Science Publishers

    Dr Alessandro Antonelli

  20. Modulatory Effects of Peroxisome Proliferator-Activated Receptor-γ on CXCR3 Chemokines

    Article • Recent Patents on Inflammation & Allergy Drug Discovery, July 2014, Bentham Science Publishers

    Dr Alessandro Antonelli

  21. IP-10 in Autoimmune Thyroiditis

    Article • Hormone and Metabolic Research, June 2014, Thieme Publishing Group

    Dr Alessandro Antonelli

  22. CLM94, a Novel Cyclic Amide with Anti-VEGFR-2 and Antiangiogenic Properties, Is Active against Primary Anaplastic Thyroid Cancerin Vitroandin Vivo

    Article • The Journal of Clinical Endocrinology & Metabolism, April 2012, Endocrine Society

    Professor Guido Bocci, Dr Alessandro Antonelli